The National Rosacea Society (NRS) funded research study on the role of cathelicidins in rosacea (see associated article) was recently published by Yamasaki et al. in Nature Medicine, one of the most prestigious medical scientific journals.1 It not only alerted the medical community to these new findings, but raised public awareness of rosacea through media coverage nationwide.
The paper was covered by newspapers across the country as a result of reports by Associated Press, United Press International, the Los Angeles Times syndicate and many others. The discovery was also featured on network and local television and in national magazines.
"This breakthrough research was made possible by the membership donations of individuals who join the NRS and contributed to medical research," said Dr. Jonathan Wilkin, chairman of the NRS Medical Advisory Board. "With continued support, our research grants program should continue to make major discoveries toward improving the treatment, prevention and potential cure of this often life-disruptive disorder."
The National Rosacea Society is a 501(c)(3) nonprofit organization whose mission is to improve the lives of people with rosacea by raising awareness, providing public health information and supporting medical research on this widespread but little-known disorder. The information the Society provides should not be considered medical advice, nor is it intended to replace
consultation with a qualified physician. The Society does not evaluate, endorse or recommend any particular medications, products, equipment or treatments. Rosacea may vary substantially from one patient to another, and treatment must be tailored by a physician for each individual case. For more information, visit About Us.